You have 9 free searches left this month | for more free features.

Cholangiocarcinoma

Showing 1 - 25 of 1,049

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 25, 2023

Precision Medicine for Combined

Recruiting
  • Liver Cancer
  • phenotyping
  • Créteil, France
    Julien Calderaro
Nov 17, 2023

Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Nov 5, 2023

Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

Not yet recruiting
  • Combined Hepatocellular Cholangiocarcinoma
  • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
  • (no location specified)
Sep 10, 2023

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

Not yet recruiting
  • Cholangiocarcinoma Non-resectable
  • Cholangiocarcinoma Metastatic
  • (no location specified)
Oct 10, 2023

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

EUS-FNA/B Versus ERCP With or Without POCS-TB in Suspected Hilar

Not yet recruiting
  • Klatskin Tumor
  • +3 more
  • The sampling method selected in patients with suspected hilar cholangiocarcinoma
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Aug 14, 2023

Patient's Experience in Medical Studies for Cholangiocarcinoma

Not yet recruiting
  • Cholangiocarcinoma
    • (no location specified)
    Jan 26, 2023

    Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

    Recruiting
    • Hilar Cholangiocarcinoma
    • +4 more
    • Endoscopic Ultrasound registration
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus University Medical Center
    Jan 11, 2023

    Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

    Recruiting
    • Cholangiocarcinoma
    • Ivosidenib Oral Tablet
    • Düsseldorf, Germany
      Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
    May 17, 2023

    Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

    Not yet recruiting
    • Cholangiocarcinoma
    • (no location specified)
    Jan 16, 2023

    Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

    Not yet recruiting
    • Cholangiocarcinoma
    • (no location specified)
    Dec 9, 2022

    Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

    Not yet recruiting
    • Locally Advanced Intrahepatic Cholangiocarcinoma
    • +4 more
    • Angiography
    • +8 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Sep 22, 2023

    Cholangiocarcinoma Metastatic Trial in China (TT-00420 (tinengotinib))

    Not yet recruiting
    • Cholangiocarcinoma Metastatic
    • TT-00420 (tinengotinib)
    • Guangzhou, Guangdong, China
    • +6 more
    Sep 26, 2023

    Perihilar Cholangiocarcinoma Trial in Amsterdam (Intrahepatic biliary stent with retrieval string)

    Recruiting
    • Perihilar Cholangiocarcinoma
    • Intrahepatic biliary stent with retrieval string
    • Amsterdam, Netherlands
      Amsterdam UMC
    May 23, 2023

    IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

    Not yet recruiting
    • IDH1-mutant Cholangiocarcinoma
    • (no location specified)
    Jun 29, 2023

    Perihilar Cholangiocarcinoma Trial in Bucharest (Endoluminal radiofrequency ablation, Endoscopic biliary stenting)

    Recruiting
    • Perihilar Cholangiocarcinoma
    • Endoluminal radiofrequency ablation
    • Endoscopic biliary stenting
    • Bucharest, Romania
      Gastroenterology Department, Colentina Hospital
    Jan 26, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

    Recruiting
    • Carcinoma
    • +4 more
    • Guangzhou, Guangdong, China
      Lei Zhang
    Jun 21, 2023

    Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

    Not yet recruiting
    • Locally Advanced Cholangiocarcinoma
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        CHA Bundang Medical Center
      Jan 24, 2023

      Predict Efficacy of GC in Treatment of Intrahepatic

      Not yet recruiting
      • Organoids
      • Intrahepatic Cholangiocarcinoma
      • gemcitabine + cisplatin
      • (no location specified)
      Nov 30, 2022

      Advanced Cholangiocarcinoma Trial in Hangzhou (Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin)

      Not yet recruiting
      • Advanced Cholangiocarcinoma
      • Lenvatinib, tislelizumab, gemcitabine and cisplatin
      • Gemcitabine and cisplatin
      • Hangzhou, Zhejiang, China
        The Second Affiliated Hospital, Zhejiang University School of Me
      Apr 10, 2023

      Lymph Node Metastasis Status in Cholangiocarcinoma Patients

      Recruiting
      • Cholangiocarcinoma
      • No interventions.
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Feb 1, 2023

      Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

      Not yet recruiting
      • Advanced Cholangiocarcinoma
      • +2 more
      • (no location specified)
      Feb 3, 2023